Scientists have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for longer. A team ...

Dr Stephen John Sammut, a clinician scientist at The Institute of Cancer Research, London, has been awarded one of the eight 2025 research prizes from the Lister Institute of Preventive Medicine.

Scientists have discovered clues which may explain why some treatments stop working for people with bowel cancer – causing around 16,800 deaths in the UK every year. The study, led by researchers at ...

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer. Research published in the journal Blood ...

A promising new therapy can help patients with aggressive advanced breast cancer live longer and delay the need for further chemotherapy, new research has shown. Final results of the INAVO120 study, ...

News from ASCO 2025 From 30 May to 3 June, the world’s leading oncologists and researchers, including scientists from The Institute of Cancer Research, London, will converge at the 2025 American ...

ASCO 2025: AI test determines best prostate cancer treatment – which could save NHS moneyA new AI test can pick out which men with high-risk prostate cancer that has not spread will require ...

A new frontier in cancer research: the rise of radiotheranostics Radiotheranostics is an exciting new field that has the potential to transform how cancers are detected and treated. Robbie Lockyer ...

ICR welcomes approval for new ovarian cancer drug combinationThe Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for ovarian cancer by the US ...